 RATIONALE: Treatment for diffuse large B-cell non-Hodgkins lymphoma may cause side effects and secondary cancers later in life. An observational study that evaluates patients after undergoing six courses of combination chemotherapy with or without rituximab and radiation therapy may help doctors predict a patients response to this treatment and help plan the best treatment. 